Literature DB >> 33594613

ERVs-TLR3-IRF axis is linked to myelodysplastic syndrome pathogenesis.

Roberta Taiane Germano de Oliveira1,2,3, João Victor Alves Cordeiro1,2,3, Bruna Ferreira Vitoriano1,2,4, Mayara Magna de Lima Melo1,2,3, Letícia Rodrigues Sampaio1,2, Daniela de Paula Borges1,2,3, Silvia Maria Meira Magalhães1,5,3, Ronald Feitosa Pinheiro6,7,8,9,10,11.   

Abstract

Toll-like receptors are mutated or overexpressed in up to 50% of patients with myelodysplastic syndrome (MDS). Endogenous retroviruses (ERV) trigger TLR3 leading to interferon regulatory genes (IRFs) activation. We evaluated if the ERVs-TLR3-IRF axis activation would be linked to MDS pathogenesis and we also conducted a detailed cancer analysis of the ERVs, TLR3 and IRFs gene expression in 30 cancer types using GEPIA database. Seventy-nine bone marrow samples from patients with MDS were evaluated for cytogenetics and quantitative real‑time PCR of TLR3, ERVK6, ERVW-1, ERV3-1, IRF3 and IRF7. Patients with dyserythropoiesis showed higher TLR3 (p = 0.035), ERVK6 (p = 0.001), ERVW1 (p = 0.045) and ERV3-1 (p = 0.016) expression than patients without dyserythropoiesis. Upregulation of Interferon Regulatory Factors, IRF3 and IRF7, was associated with poor prognostic markers in MDS such as > 10% of blasts (p = 0.003-IRF3; p = 0.009-IRF7), low platelets count (< 50.000/mm3) (p = 0.001-IRF3; p = 0.021-IRF7), transfusion dependence (p = 0.014-IRF3) and chromosomal abnormalities (p = 0.036-IRF7). We found strong correlations between ERVK6-ERVW1 (r = 0.800; r2 = 0.640; p = 0.000), ERVW1-ERV3-1 (r = 0.715; r2 = 0.511; p = 0.000), and IRF7-IRF3 (r = 0.567; r2 = 0.321; p = 0.000) and moderate correlation between ERVK6-ERV3-1(r = 0.485; r2 = 0.235; p = 0.000), ERVW1-IRF7 (r = 0.389; r2 = 0.151; p = 0.001), ERVW1-IRF3 (r = 0.357; r2 = 0.127; p = 0.004), ERV3-1-IRF7 (r = 0.314; r2 = 0.098; p = 0.009), and ERV3-1-IRF3 (r = 0.324; r2 = 0.104; p = 0.007). Using GEPIA Database in 30 cancer types, we detected a typical pattern of upregulation as here presented in MDS. We suggest TLR3 activation by ERVs is linked to MDS pathogenesis leading to bone marrow failure. Abnormal double-stranded RNA (dsRNA) expression of Endogenous Retroviruses (ERV) triggers TLR3 hyperactivation. This induces IRF3, IRF7, and NF-kB to translocate to the nucleus and activate transcription of IFNα/β which binds to the type I-IFN receptor promoting interferon response. Thus, just as TLR4 induces a crucial myeloid shift, the ERVs-TLR3 axis may play an important role in establishing one of the most striking characteristics in MDS, dyserythropoiesis.

Entities:  

Keywords:  Endogenous retroviruses; Interferon regulatory genes; Myelodysplastic syndrome; Toll-like receptors

Year:  2021        PMID: 33594613     DOI: 10.1007/s12032-021-01466-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  19 in total

1.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Authors:  Katherine B Chiappinelli; Pamela L Strissel; Alexis Desrichard; Huili Li; Christine Henke; Benjamin Akman; Alexander Hein; Neal S Rote; Leslie M Cope; Alexandra Snyder; Vladimir Makarov; Sadna Budhu; Sadna Buhu; Dennis J Slamon; Jedd D Wolchok; Drew M Pardoll; Matthias W Beckmann; Cynthia A Zahnow; Taha Merghoub; Taha Mergoub; Timothy A Chan; Stephen B Baylin; Reiner Strick
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

Review 2.  The molecular pathogenesis of the myelodysplastic syndromes.

Authors:  Andrea Pellagatti; Jacqueline Boultwood
Journal:  Eur J Haematol       Date:  2015-02-20       Impact factor: 2.997

Review 3.  Toll-like receptors.

Authors:  Eva Marie Y Moresco; Diantha LaVine; Bruce Beutler
Journal:  Curr Biol       Date:  2011-07-12       Impact factor: 10.834

4.  Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Malin Hultcrantz; Åsa R Derolf; Ola Landgren; Lynn R Goldin
Journal:  J Clin Oncol       Date:  2011-06-20       Impact factor: 44.544

5.  Toll-like receptor alterations in myelodysplastic syndrome.

Authors:  Y Wei; S Dimicoli; C Bueso-Ramos; R Chen; H Yang; D Neuberg; S Pierce; Y Jia; H Zheng; H Wang; X Wang; M Nguyen; S A Wang; B Ebert; R Bejar; R Levine; O Abdel-Wahab; M Kleppe; I Ganan-Gomez; H Kantarjian; G Garcia-Manero
Journal:  Leukemia       Date:  2013-06-14       Impact factor: 11.528

6.  Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

Authors:  Kimberly P Dunsmore; Stuart S Winter; Meenakshi Devidas; Brent L Wood; Natia Esiashvili; Zhiguo Chen; Nancy Eisenberg; Nikki Briegel; Robert J Hayashi; Julie M Gastier-Foster; Andrew J Carroll; Nyla A Heerema; Barbara L Asselin; Karen R Rabin; Patrick A Zweidler-Mckay; Elizabeth A Raetz; Mignon L Loh; Kirk R Schultz; Naomi J Winick; William L Carroll; Stephen P Hunger
Journal:  J Clin Oncol       Date:  2020-08-19       Impact factor: 44.544

Review 7.  Chronic immune response dysregulation in MDS pathogenesis.

Authors:  Laura Barreyro; Timothy M Chlon; Daniel T Starczynowski
Journal:  Blood       Date:  2018-08-13       Impact factor: 22.113

8.  SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients.

Authors:  Yi-Wei Wang; Shao-Dan Zhang; Wen-Ji Xue; Mei-Ling Zhu; Lei-Zhen Zheng
Journal:  Chin J Cancer       Date:  2015-12-14

Review 9.  Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease.

Authors:  Aleksandra Antonczyk; Bart Krist; Malgorzata Sajek; Agata Michalska; Anna Piaszyk-Borychowska; Martyna Plens-Galaska; Joanna Wesoly; Hans A R Bluyssen
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

Review 10.  Toll-like receptors in immunity and inflammatory diseases: Past, present, and future.

Authors:  Kumar Vijay
Journal:  Int Immunopharmacol       Date:  2018-05-04       Impact factor: 4.932

View more
  1 in total

1.  Global Proteomics Analysis of Bone Marrow: Establishing Talin-1 and Centrosomal Protein of 55 kDa as Potential Molecular Signatures for Myelodysplastic Syndromes.

Authors:  Arlindo A Moura; Maria Julia B Bezerra; Aline M A Martins; Daniela P Borges; Roberta T G Oliveira; Raphaela M Oliveira; Kaio M Farias; Arabela G Viana; Guilherme G C Carvalho; Carlos R K Paier; Marcelo V Sousa; Wagner Fontes; Carlos A O Ricart; Maria Elisabete A Moraes; Silvia M M Magalhães; Cristiana L M Furtado; Manoel O Moraes-Filho; Claudia Pessoa; Ronald F Pinheiro
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.